Abstract: Endocytosis is the most prevalent entry port for viruses into cells, but viruses must escape from the lumen of endosomes to ensure that viral genomes reach a site for replication and progeny formation. Endosomal escape also helps viruses bypass endo-lysosomal degradation and presentation to certain toll-like intrinsic immunity receptors. The mechanisms for cytosolic delivery of non-enveloped viruses or nucleocapsids from enveloped viruses are poorly understood, in part because no quantitative assays are readily available, which directly measure the penetration of viruses into the cytosol. Following uptake by clathrin-mediated endocytosis or macropinocytosis, the non-enveloped adenoviruses penetrate from endosomes to the cytosol, and they traffic with cellular motors on microtubules to the nucleus for replication. In this study, we present a novel single cell imaging assay, which quantitatively measures individual cytosolic viruses and distinguishes them from endosomal viruses or viruses at the plasma membrane. Using this assay, we show that the penetration of human adenoviruses from the species C and B occurs rapidly after virus uptake. Efficient penetration does not require acidic pH in endosomes. This assay is versatile, and can be adapted to other adenoviruses, and members of other non-enveloped and enveloped virus families. 
Introduction
Cell entry of viruses involves crossing of the plasma membrane, or an endosomal membrane following endocytic uptake. In fact, endocytosis is the major pathway for virus infections (for recent reviews, see 1, 2-5). Enveloped viruses are well known to fuse their lipid membrane with the plasma membrane or the endosomal membrane, and thereby deliver their internal core structures into the cytoplasm. In contrast, the membrane penetration of non-enveloped viruses is less well understood, but equally important, since it gives rise to cytosolic viruses which are sensed by intrinsic and innate host defense systems (for reviews, see 6, 7). Central to non-enveloped virus penetration is a virally encoded membrane lytic factor, which either forms a pore on the limiting membrane, causes disintegration, or locally modifies the host membrane composition (reviewed in, 8, 9) . This eventually enables the viral capsid to traverse the membrane barrier and access the cytosol. In intact non-enveloped viruses the membrane lytic factor is internal and its exposure requires a metastable capsid structure that can undergo structural rearrangements in response to cellular cues. The precise molecular mechanisms by which these membrane lytic factors bring about the virus penetration, or the host components that participate in the process, are poorly characterized. One issue that has hampered the progress is the lack of suitable assays that can quantitatively and directly measure virus penetration efficiency in infected cells.
Human adenoviruses are non-enveloped icosahedral viruses, replicating in the cell nucleus with lytic release of progeny to the medium (10) . They are classified into seven species (HAdV-A to G, 11). The ~90nm outer capsid shell is formed by the major structural protein hexon and stabilized by minor cementing proteins (12, 13) .
Proteolytic processing of the cementing proteins by a virion-associated protease converts the capsid into a metastable structure that is capable of undergoing a stepwise uncoating during entry, and successful delivery of the viral genome into the nucleus (14) (15) (16) . Attachment and uptake of adenoviruses into cells are mediated by vertex-associated fiber and penton base proteins, respectively, after a distinct series of motion steps on the cell surface (17) . Coxsackievirus adenovirus receptor (CAR) is the primary attachment receptor for species C adenoviruses, such as HAdV-C2
and HAdV-C5 (18, 19) , whereas integrins ανβ3 and ανβ5 mediate virus uptake via clathrin-mediated endocytosis (20) (21) (22) (23) (24) . In contrast, species B viruses bind to cells via CD46 or desmoglein 2 (25, 26) , and are internalized by macropinocytosis (27, 28) .
Following internalization, HAdV-C2/C5 viruses penetrate into the cytosol from an asyet-unidentified early endosomal compartment (15, 20) , whereas penetration of species B adenoviruses has been postulated to occur from late endosomes (29).
Escape of incoming adenoviruses from endosomes is dependent on the viral membrane lytic protein VI (30, 31). To expose protein VI from the inside of the virus, the virus uses CAR to engage in actomyosin-2-dependent drifting motions on the cell surface, and uses integrin binding for confinement (32). These two counteracting motions lead to a mechanical strain that releases fibers and causes structural changes in the particle that enable efficient exposure of protein VI (32). The escape of HAdV-C2/5 is apparently mediated by protein VI-induced disruption of an endosomal membrane, since HAdV-C2/C5 can promote delivery of co-internalized 70-kDa dextran, 25 nm parvovirus particles or membrane-impermeable bacterial toxins into the cytosol (31, 33-35). Furthermore, recombinant protein VI fragments liposomes in vitro (30). Critical for membrane disruption is an N-terminal amphipathic α-helix in protein VI (30, 31, 36, 37). In HAdV-C2_TS1 mutant virus (TS1) the capsid cementing proteins are unprocessed due to a point mutation in the viral protease (16) . This mutant virus is unable to undergo structural changes that enable penetration during entry, and the virus particles end up trapped in late endosomes/lysosomes (14, 20, 32, 38) .
A controversial question in the penetration of HAdV-C2/C5 viruses has been the role of acidic endosomal pH. Although in vitro studies have shown that acidic pH can destabilize the virion structure and promote protein VI exposure (30, 39), fragmentation of liposomes by recombinant protein VI is a pH-independent reaction (30). Furthermore, delivery of co-internalized dextran into the cytosol in HAdV-C5 infected cells has been reported to be unaffected by neutralization of endosomal pH by the vacuolar H + -ATPase inhibitor bafilomycin A1 (33). On the other hand, inhibition of endosomal acidification has been reported to reduce cytosolic delivery of co-internalized bacterial toxins (35, 40, 41) , and overall viral infection efficiency (15, 42 Hoechst 33342 (Sigma).
Materials and Methods

Cells and viruses
EM assay for penetration
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with dmso (control), Baf A1 or niclosamide for 1h as described above. Fifteen µg of HAdV-C2 was bound to cells at cold and the virus was internalized at 37°C for 30 min in the presence of dmso or the drugs. Samples were processed for electron microscopy as previously described (20) . For quantification, digital micrographs were recorded in sections across the middle of the cells imaged at 50000x magnification as described (52) . The number of viruses at the plasma membrane, in endosomes and the cytosol was determined by manual counting.
Assay for protein VI exposure
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with Baf A1, niclosamide or ammonium chloride for 1 h as described above, and the drugs were present in the medium throughout the experiment. Atto565-labeled HAdV-C5
was bound to cells at cold, and internalized at 37°C for indicated times. After internalization, intact cells were incubated with the 9C12 anti-hexon antibody on ice to tag virus particles at the cell surface. Cells were fixed with 3% paraformaldehyde and processed for anti-protein VI staining (see above, and 32). Alexa-680-conjugated goat anti-mouse and Alexa-488-conjugated goat anti-rabbit were used as secondary antibodies. The samples were imaged as described above. A custom programmed MatLab routine was used to quantify protein VI signal on endocytosed viruses, that is, Alexa-565-positive, but Alexa-680-negative viruses.
Assay for incoming nuclear protein VII
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with dmso, Baf A1 or niclosamide for 1h as described above. HAdV-C5 was bound to cells at 37°C for 30 min in the presence of dmso or drugs, after which virus inoculum was removed and cells were either fixed with 3% paraformaldehyde (30 min sample)
or further incubated at 37°C for 2.5 h in the presence of dmso or drugs before fixation (2.5 h sample). The samples were processed for immunofluorescence as described above. Anti-hexon 9C12 and Alexa-488-conjugated goat anti-mouse antibodies were used to estimate the number of virus particles bound per cell (30 min sample), and rabbit anti-protein VII (53) and Alexa-488-conjugated goat anti-rabbit antibodies were used to visualize nuclear protein VII dots in the 2.5 h sample. DAPI was used to mark the nuclear area. Cells were imaged as described above. Number of viruses per cell was analyzed by a custom programmed MatLab routine from maximum projections of confocal stacks, and the number of nuclear protein VII dots was analyzed by CellProfiler (http://cellprofiler.org).
Infection assays
To determine the effect of Baf A1 on virus infection, HeLa-Ohio cells grown on 96-well imaging plates (Greiner Bio-one) were pretreated with Baf A1 or dmso for 60 min as described above. HAdV-C5_EGFP or HAdV-B3_EGFP virus was bound to cells at 37°C for 30 min, after which virus inocula were removed and cells further incubated at 37°C for 17-18 h in growth medium containing dmso/Baf A1.
Alternatively, dmso/Baf A1 were added 2 h after removal of virus inocula. The samples were fixed, processed and imaged as described (32). DAPI stain was used to mark the nuclear area, and custom programmed MatLab routine was used to determine the average nuclear intensity of the EGFP signal, which was taken as a measure of infection efficiency. To determine the effect of niclosamide on virus infection, HeLa-Ohio cells grown on 96-well imaging plates were pretreated with niclosamide or dmso for 60 min as described above, HAdV-C5_EGFP or HAdV-B3_EGFP virus was then bound to cells at 37°C for 30 min, after which virus inocula were removed and cells further incubated at 37°C for 3.5 h in the presence of dmso/niclosamide, followed by 13-14.5 h incubation in a drug-free growth medium.
Cells were processed and analyzed as described for the Baf A1 experiment.
Results
Endocytosed HAdV-C2 rapidly escapes from endosomes
Previous studies have suggested that species C human adenoviruses, such as
HAdV-C2 and HAdV-C5, escape from early endosomes by causing disruption of the endosomal membrane (15, 20, 30) . To quantitatively monitor the escape at singlecell level, we developed the assay outlined in Following uptake, TS1 particles are transported to late endosomes (20) , and this explains the clustering of TS1 (Fig. 1B) .
To HAdV-C2 was efficiently endocytosed, and the drug did not compromise endosomal integrity, as indicated by the TS1 control (Fig. 3C) . Although HAdV-C2 escaped from endosomes less efficiently in niclosamide-treated cells (P=0.0011, two-tailed MannWhitney test compared to the control cells), the mean penetration efficiency of HAdV-C2 was 63.2%, far higher than that of TS1. Similarly, the escape of wt virus to cytosol was significantly less efficient also in NH 4 Cl treated cells than in control cells (Fig. 3D, 30 min pi) , but again the overall penetration efficiency was relatively slightly affected, in agreement with Baf A1 or niclosamide treated cells. These results strongly suggest that acidic pH in endosomes is not needed for efficient penetration.
This was in agreement with transmission-EM analyses 30 min post internalization.
No statistically significant differences were observed between control and Baf A1, or control and niclosamide samples ( Fig. 3E and 3F ).
We next analyzed the effect of Baf A1, niclosamide and NH 4 Cl on exposure of the viral membrane lytic protein VI. As previously reported (32), protein VI is inaccessible to antibodies in intact virus particles (0 min sample, cold synchronized infection), but during early steps in the entry the virus undergoes structural changes that result in exposure of protein VI epitopes (Fig. 4A) . Externalization of protein VI is a prerequisite for efficient penetration (32). HeLa-Ohio cells were pretreated with Baf A1, niclosamide or NH 4 Cl for 1 h, atto-565-labeled HAdV-C5 was bound to cells at cold, and virus was internalized at 37°C ( Fig. 4B-D) . We restricted the analysis to endocytosed particles because protein VI exposure occurs concomitantly or soon after endocytosis (our unpublished observations). The average protein VI intensity on endocytosed particles in Baf A1 treated cells was slightly higher at 10 min pi than in control dmso treated cells (Fig. 4B) . Protein VI separates from the virus particle following escape of the virus into the cytosol (32), and by 20min post internalization the protein VI intensity on endocytosed virions in Baf A1 and control samples was reduced to similar levels. No significant differences on protein VI signal on endocytosed particles were observed in control dmso or niclosamide treated cells at 10 min or 20 min pi (Fig. 4C) . Similarly, NH 4 Cl did not reduce protein VI exposure (Fig. 4D ). Taken together, these results support the conclusion that acidic pH in endosomes is not needed for efficient penetration of HAdV-C.
Effect of endosome neutralization of nuclear import of protein VII and virus infection
We tested the effects of Baf A1 and niclosamide on entry steps downstream of penetration, such as nuclear targeting of the genome-associated protein VII 2.5 h pi (Fig. 5A , B, C). Low multiplicity of infection, resulting in 4-41 bound virus particles per cell was used in the assays, and Baf A1 and dmso treated cells bound virus with equal efficiency (Fig. 5A) . As previously described (53, 58) , incoming protein VII is seen as discreet dots over the nuclear area (Fig. 5B , nuclear area defined by DAPI signal). Quantification of protein VII dots per nucleus indicated that the number of dots correlated with input virus, and similar numbers of dots were observed in dmso and Baf A1 treated cells (Fig. 5C ). Nuclear targeting of protein VII was analyzed in niclosamide treated cells as well. Protein VII puncta in niclosamide treated cells were, however, less discrete and appeared to be more diffuse than in control cells, thus hindering accurate comparisons of the signals in these two samples (data not shown). Instead, we estimated the overall virus entry efficiency in Baf A1 or niclosamide treated cells by measuring the transgene expression from HAdV-C5-EGFP, a non-replicating, E1/E3-deleted virus (45) . Surprisingly, Baf A1 treatment boosted infection efficiency by ~ 3.5-fold 17 h pi (Fig. 5D ). However, this boost was not linked to penetration, since a significant increase in infection efficiency was also seen when Baf A1 was added 2h after removal of virus inoculum. Similar analyses of niclosamide treated cells showed that HAdV-C5-EGFP infection efficiency was ~76%
of that in the control dmso cells (Fig. 5E) . Collectively, the data demonstrate that acidic pH is not required for virus penetration to the cytosol and nuclear import of viral DNA-associated protein VII, but pH neutralization by Baf A1 increases transgene expression.
Acidic endosomal pH is not required for efficient penetration of HAdV-B3
Previous studies have shown that incoming HAdV-B traffic to late endosomes and lysosomes in larger extent than HAdV-C (29). We used Alexa-488-labeled HAdV-B3
as a model to monitor the kinetics of subgroup B virus escape from endosomes, and sensitivity of the escape to neutralization of endosomal pH. HeLa-Ohio cells were permeabilised by SLO at 30 min pi showing that a significant number of viruses had penetrated into the cytosol as evidenced by their accessibility to anti-Alexa-488
antibodies, but virus clusters that were negative for anti-Alexa-488 signal were observed as well (Fig. 6A, representative images) . Quantitative assessment of uptake and escape showed that at 15 min pi, ~96% of viruses were endocytosed, and on average ~40% had penetrated into the cytosol (Fig. 6B) . At 30 min pi, the penetration efficiency was not significantly different from that at 15 min pi, but considerable cell-cell variability in the penetration efficiency was observed, similar to HAdV-C. Similar to HAdV-C, Baf A1 did not inhibit endocytosis of HAdV-B3.
Quantification of the Alexa-488 and Alexa-594 double positive particles indicated that
HAdV-B3 penetrated as efficiently in the Baf A1-treated cells as in the control cells (Fig. 6C) . The difference in penetration efficiency of the virus in control compared to niclosamide treated cells was statistically significant, but the overall penetration efficiency was still high, even in the niclosamide sample (Fig. 6D) . Taken together, these results demonstrate that acidic endosomal pH is not required for efficient penetration of HAdV-B3. We were not able to analyze effect of the drugs on HAdV-B3 protein VI exposure or protein VII nuclear import, since our antibodies did not react with HAdV-B3 (data not shown). Instead, we tested infection efficiency of a non-replicating HAdV-B3_EGFP virus in Baf A1-treated cells 18 h pi (47) . If the drug was added 1h before the virus, ~4.6-fold boost in the infection efficiency was observed (Fig. 6E) . The boost was significantly lower if the drug was added 2h after removal of the virus inoculum. A similar trend was observed in niclosamide treated cells (Fig. 6F) . Thus, both Baf A1 and niclosamide boosted HAdV-B3-EGFP infection efficiency without having a large effect on the penetration step.
Discussion
In this study, we establish a new penetration assay for adenoviruses that quantitatively measures virus escape from endosomes at single-cell level. SLOmediated perforation of the plasma membrane is used to introduce antibodies into the cytosol and accessibility of e.g. Alexa-488-labeled virus to anti-Alexa-488
antibodies distinguishes cytosolic from endosomal viruses in the permeabilised cells.
Techniques such as delivery of co-internalized dextran or bacterial toxins into the cytosol by virus-induced rupture of endosomes (e.g., 33, 35, 40, 59, 60), or counting of viruses at the plasma membrane, endosomes and cytosol by EM (e.g., 27, 28, 61) have previously been used to estimate escape of HAdV-C and HAdV-B from endosomes. However, the co-delivery assays are bulk assays without single cell resolution, and most importantly these assays estimate virus penetration only indirectly. Furthermore, interpretation of the results from co-delivery assays can be complicated by the fact that HAdV-C induces macropinocytosis and leakage of macropinosomal contents into the cytosol (22, 27) . This uptake pathway could be responsible for the delivery of bulk of the co-internalized dextran or bacterial toxins into the cytosol, but the macropinocytosis is not the infectious entry pathway at least for the HAdV-C (22) . The EM assay on the other hand directly estimates cytosolic and membrane-associated virus particles, but the assay is cumbersome and requires very high MOI.
The assay presented in this study can be used at high and low MOI. It is easy to setup because the key components are commercially available -Alexa-488, anti-Alexa-488 antibody and SLO. However, there is one limiting factor, the choice of cell lines.
Not all cells can endure the SLO permeabilisation, and some cell types detach from the dish, for example, U2OS cells. In this study, we used the HeLa-Ohio clone and A549 cells. In agreement with previous studies (e.g., 15, 29), we found that HAdV-C2 penetrates very rapidly after endocytic uptake. In a cold synchronized infection, a large fraction of viruses had escaped into the cytosol already 10 min after switching the cells to 37°C. Furthermore, the overall penetration efficiency was >60% at 20 min pi. Characterization of the early entry events for other adenovirus species is lagging behind that of HAdV-C. Our assay here is readily adaptable to other and ammonium chloride (lysomotropic weak base). Although the penetration of HAdV-C2 was affected to different degrees by these three treatments, the lysotracker control indicated that all three conditions efficiently neutralized acidic compartments in the cell. The differences in penetration must hence be due to other effects of the compounds than endosomal pH neutralization. Interestingly, especially Baf A1 and ammonium chloride significantly reduced HAdV-C2 penetration in a subpopulation of the cells, suggesting that other endosomal factors than pH enhance HAdV penetration. Interestingly, a mild acid (pH 6) treatment of cells containing surfacebound HAdV-C2 increased the release of tritium labeled choline or 51 Cr from the cells compared to cells kept at neutral pH (62, 63) . Possibly, low pH at the plasma membrane can substitute for an endosomal factor(s) in virus induced membrane perforation.
Although Baf A1 and niclosamide had relatively minor overall effects on the penetration efficiency of HAdV-C2 and HAdV-B3, a different picture emerged when the effect of these drugs was tested by EGFP-reporter viruses. In the case of HAdV-C5_EGFP virus, Baf A1 boosted infection efficiency by ~3.5-fold, whereas niclosamide reduced the infection by ~20%. In contrast, a significant infection boost was observed for HAdV-B3_EGFP virus, with both Baf A1 and niclosamide, possibly related to endosomal maturation which has been suggested to increase HAdV-C2 infection through autophagosome-endosome hybrid compartments (60) . Regardless, the data highlight that it is crucial to employ direct assays for on-target interpretation of interference and perturbation experiments.
One intriguing observation in the current study was the rather low impact of cointernalized wt viruses on the penetration efficiency of the TS1 virus. The average penetration efficiency of TS1 in the co-infection was 8.5% and 3% in TS1 single infections. The TS1 virus escapes from endosomes inefficiently because it does not undergo the structural alterations that prepare the particle for efficient protein VI exposure (14, 32), but it interacts with CAR and integrins, and is internalized by clathrin-mediated endocytosis as the wt virus (20) . HAdV-C2/C5 viruses penetrate from an as-yet-unidentified early endosomal compartment, since maturation of early endosomes to late endosomes is not required for efficient virus escape into the cytosol (20) . The observed low impact of co-internalized wt particles on TS1 penetration could imply that the two viruses are sorted to different endosomal compartments following uptake. Alternatively, the rapid penetration of wt virus may simply reduce co-localization of the two viruses in the same endosome compartment.
In summary, our study describes a quantitative single-cell assay for adenovirus escape from endosomes to the cytosol, a step that is poorly characterized at the molecular level. The assay can be used in combination with chemical inhibitors or possibly RNAi to probe for cellular regulators of the penetration step (64) . Single-cell assays are important since it is becoming increasingly evident that cell-to-cell variation is observed in many cellular phenotypes, including virus entry (64).
Correlation of virus entry and infection efficiencies with particular molecular or morphological properties of a single cell will give more accurate information about the molecular basis of a given event than an average phenotype acquired in a population assay. We expect that owing to its simplicity and reliability, the assay presented in this study also works for other non-enveloped viruses and even enveloped viruses, provided that they can be detected by an antibody in the selectively-permeabilised (E) Baf A1 boosts the infection efficiency. The experiment was carried out as described in legend to Fig. 5D , except that cells were fixed 18 h after removal of virus inoculum. In contrast to HAdV-C5_EGFP, late addition of the drug significantly reduced the infection boost.
(F) Niclosamide boosts the infection efficiency. The experiment was carried out as described in legend to Fig. 5E , except that cells were fixed 13 h after drug removal.
